Indian government reduced the prices of 39 drugs, including cancer, diabetes and TB

Indian government reduced the prices of 39 drugs, including cancer, diabetes and TB

The Indian government has reduced the price of eight commonly used medicines by changing the national list of essential medicines. The government has also reduced the prices of anti-cancer, anti-diabetic, anti-viral, anti-bacterial, anti-TB drugs, and other drugs.

These drugs are also used in the treatment of corona. Experts working on the NLEM list have removed 15 such drugs from the list. The Indian Medical Research Council (IMRC) has been working for a long time to control the prices of medicines.

Commonly used drugs have now been brought to the price ceiling. These include the anti-sugar drug teneligliptin, the popular anti-TB drugs, and the covid-19 drug ivermectin, the Rotavirus vaccine, and others.

The government began researching the list of essential drugs, which was notified in 2012 and brought to a price peak in 2016. The Standing National Committee on Medicines was then tasked with compiling a list of which drugs should be made available in sufficient quantities and in sufficient quantities.

A committee headed by Balram Bhargava, Secretary, Department of Health Research and Director, ICMR, senior officials of the Policy Commission, another committee comprising Health Secretary and Secretary, Department of Pharmaceuticals sends such lists. The second committee decides which drugs should be brought under the price ceiling.

Also Read:  Siddhagiri Gramjivan Museum Video

Share: 10

About Author:

Leave a Comment